Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Bullboard Posts
Comment by snrkidon Jun 17, 2009 6:23pm
351 Views
Post# 16079172

RE: " stability testing " ?

RE: " stability testing " ?

labumba, 

I value your opinions but are you sure this could have been done "years ago"? 

The drug that is being applied for NDA approval must be specific strength, specific formulation, capsulation etc.  This testing will not be a long term process and it must be likely done by an  independant facility to determine shelf life of product, storage conditions  etc.  Prior to determining the applied formula strength I find it hard to do testing.

When management is talking about this type of stability determination I find it very encouraging and see the light on the end. 

My understanding is that Voclosporine used for uventis may have different requirement than Voclosporine used for Psoriasis for example.  This is the same drug but requirements may differ as you can find when simply looking for information at public domain.  I personally don't see this as oversite just part of process.

happy trading....
snrkid.

Bullboard Posts